<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32149091</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2020</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication.</ArticleTitle><Pagination><StartPage>2430640</StartPage><MedlinePgn>2430640</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2430640</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/2430640</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the causative pathogen of hand, foot, and mouth disease (HFMD). However, no effective antiviral therapy is currently available. Some viruses could escape the host's innate immunity by upregulating suppressor of cytokine signaling (SOCS) proteins. Until now, whether EV71 evades the host immune system by regulating the expression of SOCS proteins remains unknown. In this study, we found that EV71 infection promoted SOCS expression at both mRNA and protein levels in vitro and in vivo. Consistently, the infectivity of EV71 was decreased significantly in the SOCS3 or SOCS1 knockdown cells, suggesting that SOCS1 and especially SOCS3 are crucial for EV71 infection. Further investigation showed that SOCS3 promoted virus infection by inhibiting interferon-induced STAT3 phosphorylation. SOCS1 and SOCS3 mRNA expressions were independent on virus-induced type I interferon expression but were blocked by the inhibitor of NF-<i>&#x3ba;</i>B. Therefore, EV71 infection stimulates the expression of SOCS proteins in an interferon-independent way and negatively regulates the JAK/STAT signaling pathway, thus escaping host immunity. All these results may add new information to the mechanism of EV71 in fighting against type I interferon responses.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Wenying Gao et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wenying</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhaolong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yongjun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5294-9790</Identifier><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4507-521X</Identifier><AffiliationInfo><Affiliation>The First Hospital of Jilin University, Institute of Virology and AIDS Research &amp; Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508032">Ifnar1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071222">Suppressor of Cytokine Signaling 1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071223">Suppressor of Cytokine Signaling 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050826">Suppressor of Cytokine Signaling Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071222" MajorTopicYN="N">Suppressor of Cytokine Signaling 1 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071223" MajorTopicYN="N">Suppressor of Cytokine Signaling 3 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050826" MajorTopicYN="N">Suppressor of Cytokine Signaling Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32149091</ArticleId><ArticleId IdType="pmc">PMC7054758</ArticleId><ArticleId IdType="doi">10.1155/2020/2430640</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin Y., Zhang R., Wu W., Duan G. Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses. 2018;10(4):p. 155. doi: 10.3390/v10040155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10040155</ArticleId><ArticleId IdType="pmc">PMC5923449</ArticleId><ArticleId IdType="pubmed">29597291</ArticleId></ArticleIdList></Reference><Reference><Citation>Alston C. I., Dix R. D. SOCS and herpesviruses, with emphasis on cytomegalovirus retinitis. Frontiers in Immunology. 2019;10 doi: 10.3389/fimmu.2019.00732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00732</ArticleId><ArticleId IdType="pmc">PMC6470272</ArticleId><ArticleId IdType="pubmed">31031749</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina G. N., Segundo F. D. S., Stenfeldt C., Arzt J., de los Santos T. The different tactics of foot-and-mouth disease virus to evade innate immunity. Frontiers in Microbiology. 2018;9 doi: 10.3389/fmicb.2018.02644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02644</ArticleId><ArticleId IdType="pmc">PMC6241212</ArticleId><ArticleId IdType="pubmed">30483224</ArticleId></ArticleIdList></Reference><Reference><Citation>Maarouf M., Rai K., Goraya M., Chen J.-L. Immune ecosystem of virus-infected host tissues. International Journal of Molecular Sciences. 2018;19(5):p. 1379. doi: 10.3390/ijms19051379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051379</ArticleId><ArticleId IdType="pmc">PMC5983771</ArticleId><ArticleId IdType="pubmed">29734779</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber G., Piehler J. The molecular basis for functional plasticity in type I interferon signaling. Trends in Immunology. 2015;36(3):139&#x2013;149. doi: 10.1016/j.it.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.01.002</ArticleId><ArticleId IdType="pubmed">25687684</ArticleId></ArticleIdList></Reference><Reference><Citation>Porritt R. A., Hertzog P. J. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends in Immunology. 2015;36(3):150&#x2013;160. doi: 10.1016/j.it.2015.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.02.002</ArticleId><ArticleId IdType="pubmed">25725583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmiest D., Sharma N., Zanin N., et al. Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex. Nature Communications. 2016;7(1) doi: 10.1038/ncomms13476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13476</ArticleId><ArticleId IdType="pmc">PMC5150223</ArticleId><ArticleId IdType="pubmed">27917878</ArticleId></ArticleIdList></Reference><Reference><Citation>Linossi E. M., Nicholson S. E. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins. Immunological Reviews. 2015;266(1):123&#x2013;133. doi: 10.1111/imr.12305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12305</ArticleId><ArticleId IdType="pubmed">26085211</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar L. N., Benveniste E. N. Viral exploitation of host SOCS protein functions. Journal of Virology. 2011;85(5):1912&#x2013;1921. doi: 10.1128/JVI.01857-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01857-10</ArticleId><ArticleId IdType="pmc">PMC3067810</ArticleId><ArticleId IdType="pubmed">21084484</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham G. A., Williams J. J. L., Nasim M. T., Palmer T. M. Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends in Pharmacological Sciences. 2019;40(5):298&#x2013;308. doi: 10.1016/j.tips.2019.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.03.001</ArticleId><ArticleId IdType="pubmed">30948191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahony R., Ahmed S., Diskin C., Stevenson N. J. SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cellular and Molecular Life Sciences. 2016;73(17):3323&#x2013;3336. doi: 10.1007/s00018-016-2234-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2234-x</ArticleId><ArticleId IdType="pmc">PMC11108554</ArticleId><ArticleId IdType="pubmed">27137184</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R. C., Schlaepfer E., Baenziger S., et al. HIV interferes with SOCS-1 and -3 expression levels driving immune activation. European Journal of Immunology. 2011;41(4):1058&#x2013;1069. doi: 10.1002/eji.201041198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201041198</ArticleId><ArticleId IdType="pubmed">21337543</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeberlein B., Hausen A. ., Bektas N., et al. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Research. 2010;148(1-2):51&#x2013;59. doi: 10.1016/j.virusres.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2009.12.003</ArticleId><ArticleId IdType="pubmed">20005910</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasukawa H., Yajima T., Duplain H., et al. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. The Journal of Clinical Investigation. 2003;111(4):469&#x2013;478. doi: 10.1172/JCI16491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI16491</ArticleId><ArticleId IdType="pmc">PMC151924</ArticleId><ArticleId IdType="pubmed">12588885</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli E. K., Schmolke M., Wolff T., et al. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathogens. 2008;4(11) doi: 10.1371/journal.ppat.1000196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000196</ArticleId><ArticleId IdType="pmc">PMC2572141</ArticleId><ArticleId IdType="pubmed">18989459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhu C., Bao W., et al. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One. 2012;7(3) doi: 10.1371/journal.pone.0032405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S. H., Wang A., Liu P. P., et al. Divergent pathogenic properties of circulating coxsackievirus A6 associated with emerging hand, foot, and mouth disease. Journal of Virology. 2018;92(11) doi: 10.1128/JVI.00303-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00303-18</ArticleId><ArticleId IdType="pmc">PMC5952127</ArticleId><ArticleId IdType="pubmed">29563294</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Chang J., Liu X., et al. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. The Journal of General Virology. 2014;95:1083&#x2013;1093. doi: 10.1099/vir.0.063560-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.063560-0</ArticleId><ArticleId IdType="pmc">PMC3983757</ArticleId><ArticleId IdType="pubmed">24496826</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitaels J., van Hoecke L., Roose K., Kochs G., Saelens X. Mx1 in hematopoietic cells protects against Thogoto Virus infection. Journal of Virology. 2019;93(15) doi: 10.1128/JVI.00193-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00193-19</ArticleId><ArticleId IdType="pmc">PMC6639282</ArticleId><ArticleId IdType="pubmed">31092574</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisching G., Wiid I., Baker B. OAS1, 2, and 3: significance during active tuberculosis? The Journal of Infectious Diseases. 2018;217(10):1517&#x2013;1521. doi: 10.1093/infdis/jiy084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy084</ArticleId><ArticleId IdType="pubmed">29452387</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhelst J., Hulpiau P., Saelens X. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiology and Molecular Biology Reviews. 2013;77(4):551&#x2013;566. doi: 10.1128/MMBR.00024-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00024-13</ArticleId><ArticleId IdType="pmc">PMC3973384</ArticleId><ArticleId IdType="pubmed">24296571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W., Lee S. H., Ahn D. G., et al. The antiviral activity of poly-&#x3b3;-glutamic acid, a polypeptide secreted by _Bacillus_ sp., through induction of CD14-dependent type I interferon responses. Biomaterials. 2013;34(37):9700&#x2013;9708. doi: 10.1016/j.biomaterials.2013.08.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2013.08.067</ArticleId><ArticleId IdType="pmc">PMC7112489</ArticleId><ArticleId IdType="pubmed">24016850</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokota S., Yokosawa N., Okabayashi T., et al. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. Journal of Virology. 2004;78(12):6282&#x2013;6286. doi: 10.1128/JVI.78.12.6282-6286.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.12.6282-6286.2004</ArticleId><ArticleId IdType="pmc">PMC416529</ArticleId><ArticleId IdType="pubmed">15163721</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodington D. W., Desai H. R., Woo M. JAK/STAT - emerging players in metabolism. Trends in Endocrinology and Metabolism. 2018;29(1):55&#x2013;65. doi: 10.1016/j.tem.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2017.11.001</ArticleId><ArticleId IdType="pubmed">29191719</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Chang L., Wang X., et al. MOV10 interacts with enterovirus 71 genomic 5'UTR and modulates viral replication. Biochemical and Biophysical Research Communications. 2016;479(3):571&#x2013;577. doi: 10.1016/j.bbrc.2016.09.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.112</ArticleId><ArticleId IdType="pubmed">27666477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu K., Dutta K., Nazmi A., Basu A. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts&#x2019; innate immune response. Cellular Immunology. 2013;285(1-2):100&#x2013;110. doi: 10.1016/j.cellimm.2013.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2013.09.005</ArticleId><ArticleId IdType="pubmed">24140964</ArticleId></ArticleIdList></Reference><Reference><Citation>Carow B., Rottenberg M. E. SOCS3, a major regulator of infection and inflammation. Frontiers in Immunology. 2014;5 doi: 10.3389/fimmu.2014.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00058</ArticleId><ArticleId IdType="pmc">PMC3928676</ArticleId><ArticleId IdType="pubmed">24600449</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirt H., Eder I. E., Puhr M., Rudnicki M. SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner. Laboratory Investigation. 2013;93(1):123&#x2013;134. doi: 10.1038/labinvest.2012.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2012.154</ArticleId><ArticleId IdType="pubmed">23108375</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins A. S., Ahmed S., Napoletano S., et al. Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-&#x3b1; responses. Journal of Leukocyte Biology. 2014;96(2):255&#x2013;263. doi: 10.1189/jlb.2A1211-608RRRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.2A1211-608RRRR</ArticleId><ArticleId IdType="pubmed">24659790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>